43
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Is cryoablation a valid option for renal cell carcinomas in direct contact with critical organs?

, ORCID Icon, , , , , , , & show all
Received 02 Feb 2024, Accepted 13 Apr 2024, Published online: 17 May 2024

References

  • Andrews JR, Atwell T, Schmit G, et al. Oncologic outcomes following partial nephrectomy and percutaneous ablation for cT1 renal masses. Eur Urol. 2019;76(2):244–251. doi: 10.1016/j.eururo.2019.04.026.
  • Breen DJ, King AJ, Patel N, et al. Image-guided cryoablation for sporadic renal cell carcinoma: three- and 5-year outcomes in 220 patients with biopsy-proven renal cell carcinoma. Radiology. 2018;289(2):554–561. doi: 10.1148/radiol.2018180249.
  • Saliken JC, McKinnon JG, Gray R. CT for monitoring cryotherapy. AJR Am J Roentgenol. 1996;166(4):853–855. doi: 10.2214/ajr.166.4.8610562.
  • Krokidis ME, Orsi F, Katsanos K, et al. CIRSE guidelines on percutaneous ablation of small renal cell carcinoma. Cardiovasc Intervent Radiol. 2017;40(2):177–191. doi: 10.1007/s00270-016-1531-y.
  • Maria T, Georgiades C. Percutaneous cryoablation for renal cell carcinoma. J Kidney Cancer VHL. 2015;2(3):105–113. doi: 10.15586/jkcvhl.2015.34.
  • Iguchi T, Matsui Y, Tomita K, et al. Complications of percutaneous cryoablation for renal tumors and methods for avoiding them. Acta Med Okayama. 2023;77(2):121–129. doi: 10.18926/AMO/65141.
  • Bodily KD, Atwell TD, Mandrekar JN, et al. Hydrodisplacement in the percutaneous cryoablation of 50 renal tumors. AJR Am J Roentgenol. 2010;194(3):779–783. doi: 10.2214/AJR.08.1570.
  • Khan F, Ho AM, Jamal JE, et al. Long-term outcomes after percutaneous renal cryoablation performed with adjunctive techniques. Clin Imaging. 2018;50:62–67. doi: 10.1016/j.clinimag.2017.12.003.
  • Weiss J, Garnon J, Cazzato RL, et al. Percutaneous hydrodissection for thermoprotection during cryoablation of periureteric and pyeloureteric junction renal cell carcinomas. Abdom Radiol (NY). 2021;46(3):1179–1187. doi: 10.1007/s00261-020-02760-8.
  • Cernic S, Marrocchio C, Ciabattoni R, et al. Percutaneous CT-Guided renal cryoablation: technical aspects, safety, and Long-Term oncological outcomes in a single center. Medicina (Kaunas). 2021;57(3):291. doi: 10.3390/medicina57030291.
  • Gobara H, Matsui Y, Uka M, et al. Percutaneous cryoablation combined with prior transcatheter arterial embolization for renal cell carcinomas of 3 cm or larger: a prospective study. Int J Clin Oncol. 2022;27(10):1589–1595. doi: 10.1007/s10147-022-02224-7.
  • Umakoshi N, Iguchi T, Matsui Y, et al. Renal cryoablation combined with prior transcatheter arterial embolization in non-dialysis patients with stage 4 or 5 chronic kidney disease: a retrospective study. Jpn J Radiol. 2023;41(9):1007–1014. doi: 10.1007/s11604-023-01416-z.
  • Gobara H, Nakatsuka A, Shimizu K, et al. Cryoablation of renal cell carcinoma for patients with stage 4 or 5 non-dialysis chronic kidney disease. Jpn J Radiol. 2019;37(6):481–486. doi: 10.1007/s11604-019-00821-7.
  • Matsui Y, Hiraki T, Gobara H, et al. Percutaneous thermal ablation for renal cell carcinoma in patients with Birt-Hogg-Dubé syndrome. Diagn Interv Imaging. 2019;100(11):671–677. doi: 10.1016/j.diii.2019.06.009.
  • Uka M, Iguchi T, Okawa N, et al. Percutaneous cryoablation for clinical T3a renal cell carcinoma (< 7 cm) with segmental vein involvement or perinephric fat invasion based on preoperative evaluation of high-resolution multidetector computed tomography scan. Jpn J Radiol. 2022;40(11):1201–1209. doi: 10.1007/s11604-022-01297-8.
  • Georgiades C, Rodriguez R, Azene E, et al. Determination of the nonlethal margin inside the visible “ice-ball” during percutaneous cryoablation of renal tissue. Cardiovasc Intervent Radiol. 2013;36(3):783–790. doi: 10.1007/s00270-012-0470-5.
  • Gobara H, Hiraki T, Iguchi T, et al. Acute bowel injury due to cryoablation for renal cell carcinoma: correlated radiologic and pathologic findings. Acta Med Okayama. 2016;70(6):511–514. doi: 10.18926/AMO/54817.
  • Seager M, Kumar S, Lim E, et al. Renal cryoablation - a practical guide for interventional radiologists. Br J Radiol. 2021;94(1118):20200854. doi: 10.1259/bjr.20200854.
  • Miyazaki M, Iguchi T, Takaki H, et al. Ablation protocols and ancillary procedures in tumor ablation therapy: consensus from japanese experts. Jpn J Radiol. 2016;34(9):647–656. doi: 10.1007/s11604-016-0569-8.
  • Yamanaka T, Yamakado K, Yamada T, et al. CT-Guided percutaneous cryoablation in renal cell carcinoma: factors affecting local tumor control. J Vasc Interv Radiol. 2015;26(8):1147–1153. doi: 10.1016/j.jvir.2015.04.031.
  • Tomita K, Iguchi T, Matsui Y, et al. Pneumodissection during percutaneous renal cryoablation resulting in massive subcutaneous and mediastinal emphysema. Diagn Interv Imaging. 2022;103(4):231–232. doi: 10.1016/j.diii.2021.11.003.
  • Sone M, Arai Y, Sugawara S, et al. Angio-CT–assisted balloon dissection: protection of the adjacent intestine during cryoablation for patients with renal cancer. J Vasc Interv Radiol. 2016;27(9):1414–1419. doi: 10.1016/j.jvir.2016.02.028.
  • Littrup PJ, Ahmed A, Aoun HD, et al. CT-guided percutaneous cryotherapy of renal masses. J Vasc Interv Radiol. 2007;18(3):383–392. doi: 10.1016/j.jvir.2006.12.007.
  • Yamagami T, Yoshimatsu R, Kajiwara K, et al. Protection from injury of organs adjacent to a renal tumor during percutaneous cryoablation. Int J Urol. 2019;26(8):785–790. doi: 10.1111/iju.14013.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.